Robert Gallop, PhD

Articles by Robert Gallop, PhD

Impact of a Medical Home Model on Costs and Utilization Among Comorbid HIV-Positive Medicaid Patients

ByPaul Crits-Christoph, PhD,Robert Gallop, PhD,Elizabeth Noll, PhD,Aileen Rothbard, ScD,Caroline K. Diehl, BS,Mary Beth Connolly Gibbons, PhD,Robert Gross, MD, MSCE,Karin V. Rhodes, MD, MS

August 16th 2018

Among HIV-positive Medicaid patients with comorbid medical and psychiatric disorders, there was increased outpatient service utilization, yet relative cost savings, for patients who were treated in patient-centered medical homes.

Latest Updated Articles

Impact of a Medical Home Model on Costs and Utilization Among Comorbid HIV-Positive Medicaid Patients
Published: August 16th 2018 | Updated:

Robert Gallop, PhD

Articles by Robert Gallop, PhD

Impact of a Medical Home Model on Costs and Utilization Among Comorbid HIV-Positive Medicaid Patients

Latest Updated Articles

Trending on AJMC

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

Revumenib Granted FDA Approval for R/R NPM1-Mutated AML

How Can Women Control Their Weight During Menopause?

AMCP Nexus Bringing the Latest on Health Policy, Drug Access, and Value-Based Care